Article Details
Retrieved on: 2021-03-24 20:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that SYNB8802 has ...
Article found on: www.prnewswire.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here